Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%

Pennsaid 2% Already Approved for Marketing in the United States and Russia MISSISSAUGA, ON, May 15, 2017 -- (Healthcare Sales & Marketing Network) - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI), a commercial healthcare company with a portf... Biopharmaceuticals Nuvo Pharmaceuticals, Pennsaid, diclofenac, ankle, sprain
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news